Pingfang Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pingfang Tian has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Ying Li
College of Biochemical Engineering, Beijing Union University, Beijing, 100023, PR China
13 shared publicationsPeng Zhao
College of Bioscience and Resources Environment, Beijing University of Agriculture, Beijing 102206, P. R. China
12 shared publicationsXizhen Ge
College of Biochemical Engineering
12 shared publicationsShimin Wu
Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
7 shared publicationsQingyang Li
School of Food Science and Engineering, South China University of Technology, Guangzhou 510641, PR China
6 shared publicationsTianwei Tan
Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, People's Republic of China
6 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24  (1)
A coordinated toolbox strategy integrating direct pathogen suppression, host-associated responses, and microbiome remodeling for crop protection
Although integrated pest management promotes the coordinated use of multiple disease-control tactics, single sprayable formulations that consolidate complementary crop-protection functions remain underdeveloped. Here, we combined semi-rational screening with supramolecular co-assembly to construct a ternary nanoassembly comprising glycyrrhizic acid (GA, a plant-derived amphiphile), magnolol (MN, a plant-derived antifungal phenolic), and Zn2+, termed G-M@Zn NPs. Compared with free MN, G-M@Zn NPs enhanced MN photostability by 3.7-fold and increased rainfastness by 2.1-fold, indicating improved formulation persistence under simulated photolytic and wash-off stresses. The nanoformulation exhibited broad-spectrum antifungal activity in vitro against representative phytopathogenic fungi and, in a wheat-spike infection model of Fusarium graminearum, reduced the disease index from 52.5 ± 2.46 in the infected control to 22.3 ± 3.4. Under toxin-inducing conditions, G-M@Zn NPs also reduced deoxynivalenol (DON) accumulation and downregulated key TRI genes. Mechanistic assays linked the antifungal activity of G-M@Zn NPs to fungal membrane injury and mitochondria-associated oxidative stress in F. graminearum, with free MN eliciting qualitatively similar but weaker responses. G-M@Zn NP treatment was also accompanied by host defence-related physiological and metabolic responses involving redox regulation and tryptophan/indole-related pathways, together with treatment-associated shifts in the wheat spike microbiome. Preliminary biosafety assays indicated crop compatibility under the tested conditions and low acute toxicity toward earthworms. Serial-passage assays with F. graminearum showed only a modest increase in EC50 after eight passages. Overall, this ternary co-assembly provides a strategy for integrating complementary crop-protection functions within a single multifunctional nanoformulation and supports IPM-compatible control of F. graminearum infection in wheat. It may also inform the design of bioinspired nanopesticide systems that combine improved formulation persistence with direct antifungal activity and crop-associated biological responses.
- 4 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24  (1)
Open AccessA coordinated toolbox strategy integrating direct pathogen suppression, host-associated responses, and microbiome remodeling for crop protection
Although integrated pest management promotes the coordinated use of multiple disease-control tactics, single sprayable formulations that consolidate complementary crop-protection functions remain underdeveloped. Here, we combined semi-rational screening with supramolecular co-assembly to construct a ternary nanoassembly comprising glycyrrhizic acid (GA, a plant-derived amphiphile), magnolol (MN, a plant-derived antifungal phenolic), and Zn2+, termed G-M@Zn NPs. Compared with free MN, G-M@Zn NPs enhanced MN photostability by 3.7-fold and increased rainfastness by 2.1-fold, indicating improved formulation persistence under simulated photolytic and wash-off stresses. The nanoformulation exhibited broad-spectrum antifungal activity in vitro against representative phytopathogenic fungi and, in a wheat-spike infection model of Fusarium graminearum, reduced the disease index from 52.5 ± 2.46 in the infected control to 22.3 ± 3.4. Under toxin-inducing conditions, G-M@Zn NPs also reduced deoxynivalenol (DON) accumulation and downregulated key TRI genes. Mechanistic assays linked the antifungal activity of G-M@Zn NPs to fungal membrane injury and mitochondria-associated oxidative stress in F. graminearum, with free MN eliciting qualitatively similar but weaker responses. G-M@Zn NP treatment was also accompanied by host defence-related physiological and metabolic responses involving redox regulation and tryptophan/indole-related pathways, together with treatment-associated shifts in the wheat spike microbiome. Preliminary biosafety assays indicated crop compatibility under the tested conditions and low acute toxicity toward earthworms. Serial-passage assays with F. graminearum showed only a modest increase in EC50 after eight passages. Overall, this ternary co-assembly provides a strategy for integrating complementary crop-protection functions within a single multifunctional nanoformulation and supports IPM-compatible control of F. graminearum infection in wheat. It may also inform the design of bioinspired nanopesticide systems that combine improved formulation persistence with direct antifungal activity and crop-associated biological responses.
- 16 January 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 341  (Pt 2) , 150331
Decoupling adhesion from carbon metabolism via FimA deletion in Klebsiella pneumoniae type 1 pili
- 16 January 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 341  (Pt 2) , 150331
Decoupling adhesion from carbon metabolism via FimA deletion in Klebsiella pneumoniae type 1 pili
- 18 July 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 14  (8) , 2939-2954
Contemplating Bioproduction of Type-I Insect Sex Pheromones in Saccharomyces cerevisiae
Insect sex pheromones (ISPs) can act as baits to trap heterosexual insects, representing a promising biocontrol strategy. However, current industrial production of ISPs relies largely on conventional chemical synthesis, which shows drawbacks, such as low yield and environmental pollution. Fortunately, remarkable progress in metabolic pathway engineering opens the possibility of biomanufacturing ISPs in microbial cell factories, which seems to be superior to chemical synthesis. While previous reviews have summarized pathways and enzymes related to the biosynthesis of ISPs, this review zeroes in on the enzymatic structures and catalytic mechanisms. In particular, we propose a potential pathway and discuss strategies for the heterologous biosynthesis of type-I ISPs in Saccharomyces cerevisiae, a suitable host for expressing enzymes, especially those requiring post-translational modifications. Overall, this review seeks to provide valuable insights for the complete biosynthesis of type-I ISPs.
- 18 July 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 14  (8) , 2939-2954
Contemplating Bioproduction of Type-I Insect Sex Pheromones in Saccharomyces cerevisiae
Insect sex pheromones (ISPs) can act as baits to trap heterosexual insects, representing a promising biocontrol strategy. However, current industrial production of ISPs relies largely on conventional chemical synthesis, which shows drawbacks, such as low yield and environmental pollution. Fortunately, remarkable progress in metabolic pathway engineering opens the possibility of biomanufacturing ISPs in microbial cell factories, which seems to be superior to chemical synthesis. While previous reviews have summarized pathways and enzymes related to the biosynthesis of ISPs, this review zeroes in on the enzymatic structures and catalytic mechanisms. In particular, we propose a potential pathway and discuss strategies for the heterologous biosynthesis of type-I ISPs in Saccharomyces cerevisiae, a suitable host for expressing enzymes, especially those requiring post-translational modifications. Overall, this review seeks to provide valuable insights for the complete biosynthesis of type-I ISPs.
- 24 June 2025
- Published by Elsevier in Pesticide Biochemistry and Physiology
- Vol. 213, 106523
Dual-functional berberine-magnolol co-assembled nanoparticles inhibit Fusarium graminearum growth and mycotoxin production
- 24 June 2025
- Published by Elsevier in Pesticide Biochemistry and Physiology
- Vol. 213, 106523
Dual-functional berberine-magnolol co-assembled nanoparticles inhibit Fusarium graminearum growth and mycotoxin production
- Open Access
Systematic Investigations of the Huperzine A—Producing Endophytic Fungi of Huperzia serrata in China and Fermentation Optimization Using OSMAC Strategy
Huperzine A (HupA) can alleviate Alzheimer’s disease due to its reversible inhibition of acetylcholinesterase (AChE). The chemical synthesis and plant extraction of HupA is plagued by route complexity and resource scarcity, respectively. Although some endophytic fungi from Huperzia serrata can independently biosynthesize HupA, their yields are trivial. After a comprehensive investigation of HupA-producing H. serrata across China, we focused on the endophytic fungi from Hunan and Hubei provinces, which demonstrated high-level HupA. Morphological characteristics and internal transcriptional sequence (ITS) analysis revealed their diversity. Among the four HupA-producing endophytic fungi, Colletotrichum kahawae is the best-performing and was thus subjected to fermentation optimization. When its fermentation medium was supplemented with H. serrata flavonoids daidzein and apigenin, HupA yields reached 58.38 μg/g (dry cell weight, dcw) and 72.21 μg/g dcw, respectively. In contrast, the addition of L-lysine and H. serrata extracts led to yields of 50.17 μg/g dcw and 255.32 μg/g dcw, respectively. Transcriptomic analysis revealed that H. serrata extracts substantially upregulated the expression of HupA biosynthesis genes in C. kahawae. Overall, H. serrata extracts outperformed L-lysine, daidzein, and apigenin in boosting HupA production, as they encompass all the necessary nutrients for C. kahawae growth. This study not only connotes a nutritional exchange between H. serrata and C. kahawae during long-term coevolution but also offers insights for harnessing plant extracts for the overproduction of desired metabolites in endophytic fungi.
Open AccessSystematic Investigations of the Huperzine A—Producing Endophytic Fungi of Huperzia serrata in China and Fermentation Optimization Using OSMAC Strategy
Huperzine A (HupA) can alleviate Alzheimer’s disease due to its reversible inhibition of acetylcholinesterase (AChE). The chemical synthesis and plant extraction of HupA is plagued by route complexity and resource scarcity, respectively. Although some endophytic fungi from Huperzia serrata can independently biosynthesize HupA, their yields are trivial. After a comprehensive investigation of HupA-producing H. serrata across China, we focused on the endophytic fungi from Hunan and Hubei provinces, which demonstrated high-level HupA. Morphological characteristics and internal transcriptional sequence (ITS) analysis revealed their diversity. Among the four HupA-producing endophytic fungi, Colletotrichum kahawae is the best-performing and was thus subjected to fermentation optimization. When its fermentation medium was supplemented with H. serrata flavonoids daidzein and apigenin, HupA yields reached 58.38 μg/g (dry cell weight, dcw) and 72.21 μg/g dcw, respectively. In contrast, the addition of L-lysine and H. serrata extracts led to yields of 50.17 μg/g dcw and 255.32 μg/g dcw, respectively. Transcriptomic analysis revealed that H. serrata extracts substantially upregulated the expression of HupA biosynthesis genes in C. kahawae. Overall, H. serrata extracts outperformed L-lysine, daidzein, and apigenin in boosting HupA production, as they encompass all the necessary nutrients for C. kahawae growth. This study not only connotes a nutritional exchange between H. serrata and C. kahawae during long-term coevolution but also offers insights for harnessing plant extracts for the overproduction of desired metabolites in endophytic fungi.
- 9 January 2025
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 13  (2) , 778-790
Metabolic Engineering of Escherichia coli for De Novo Biosynthesis of the Platform Chemical Pelletierine
- 9 January 2025
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 13  (2) , 778-790
Metabolic Engineering of Escherichia coli for De Novo Biosynthesis of the Platform Chemical Pelletierine
- Open Access
Rethinking Biosynthesis of Aclacinomycin A
Aclacinomycin A (ACM-A) is an anthracycline antitumor agent widely used in clinical practice. The current industrial production of ACM-A relies primarily on chemical synthesis and microbial fermentation. However, chemical synthesis involves multiple reactions which give rise to high production costs and environmental pollution. Microbial fermentation is a sustainable strategy, yet the current fermentation yield is too low to satisfy market demand. Hence, strain improvement is highly desirable, and tremendous endeavors have been made to decipher biosynthesis pathways and modify key enzymes. In this review, we comprehensively describe the reported biosynthesis pathways, key enzymes, and, especially, catalytic mechanisms. In addition, we come up with strategies to uncover unknown enzymes and improve the activities of rate-limiting enzymes. Overall, this review aims to provide valuable insights for complete biosynthesis of ACM-A.
Open AccessRethinking Biosynthesis of Aclacinomycin A
Aclacinomycin A (ACM-A) is an anthracycline antitumor agent widely used in clinical practice. The current industrial production of ACM-A relies primarily on chemical synthesis and microbial fermentation. However, chemical synthesis involves multiple reactions which give rise to high production costs and environmental pollution. Microbial fermentation is a sustainable strategy, yet the current fermentation yield is too low to satisfy market demand. Hence, strain improvement is highly desirable, and tremendous endeavors have been made to decipher biosynthesis pathways and modify key enzymes. In this review, we comprehensively describe the reported biosynthesis pathways, key enzymes, and, especially, catalytic mechanisms. In addition, we come up with strategies to uncover unknown enzymes and improve the activities of rate-limiting enzymes. Overall, this review aims to provide valuable insights for complete biosynthesis of ACM-A.
- 5 October 2022
- Published by Elsevier in Biotechnology Advances
- Vol. 61, 108047
CRISPR-Cas13 technology portfolio and alliance with other genetic tools
- 5 October 2022
- Published by Elsevier in Biotechnology Advances
- Vol. 61, 108047
CRISPR-Cas13 technology portfolio and alliance with other genetic tools
- 12 September 2022
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 106  (19-20) , 6383-6396
Genomic landscapes of bacterial transposons and their applications in strain improvement
Transposons are mobile genetic elements that can give rise to gene mutation and genome rearrangement. Due to their mobility, transposons have been exploite
- 12 September 2022
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 106  (19-20) , 6383-6396
Genomic landscapes of bacterial transposons and their applications in strain improvement
Transposons are mobile genetic elements that can give rise to gene mutation and genome rearrangement. Due to their mobility, transposons have been exploite
- 30 July 2022
- Published by Elsevier in Biotechnology Advances
- Vol. 60, 108026
Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease
- 30 July 2022
- Published by Elsevier in Biotechnology Advances
- Vol. 60, 108026
Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease